|
Diabetes, Vol 44, Issue 5 550-554, Copyright © 1995 by American Diabetes Association
Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice
PW Rohane, A Shimada, DT Kim, CT Edwards, B Charlton, LD Shultz and CG Fathman
Stanford University School of Medicine, California 94305-5111, USA.
In an effort to study the development of diabetes in NOD mice, our
laboratory developed a novel adoptive transfer model using NOD-scid/scid
(NOD-scid) mice as recipients of islet-infiltrating lymphocytes from donor
prediabetic female NOD mice. We first confirmed previous results that
demonstrated that splenocytes of diabetic and prediabetic female NOD mice
could transfer diabetes to NOD-scid mice. We demonstrated that the kinetics
of disease transfer were dependent on the age of transferred lymphocytes
and reiterated the kinetics of diabetes in conventional female NOD mice. We
then demonstrated that islet-infiltrating lymphocytes from prediabetic
female NOD mice could transfer diabetes. In contrast with the age-dependent
transfer of diabetes seen using splenocytes, islet-infiltrating lymphocytes
obtained from prediabetic female NOD mice aged > or = 40 days rapidly
transferred diabetes to NOD-scid recipients. The time required to transfer
insulin-dependent diabetes mellitus (IDDM) using islet-infiltrating
lymphocytes from young prediabetic mice (25 +/- 9 days) was not
statistically different from the time required to transfer IDDM using
splenocytes from overtly diabetic mice (32 +/- 5 days). Cotransfer of
splenocyte cells or CD4+, but not CD8+ spleen cells, from 60- to 80-day-old
prediabetic female NOD mice together with either splenocytes from diabetic
mice or islet-infiltrating lymphocytes from prediabetic NOD mice delayed
the rapid transfer of IDDM, suggesting that CD4+ cells mediated
immunoregulation. Use of the NOD-scid islet-infiltrating
lymphocyte-adoptive transfer model should help elucidate the
pathophysiology of the early inflammatory events leading to insulitis and
subsequent beta-cell destruction.(ABSTRACT TRUNCATED AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Perone, S. Bertera, Z. S. Tawadrous, W. J. Shufesky, J. D. Piganelli, L. G. Baum, M. Trucco, and A. E. Morelli
Dendritic Cells Expressing Transgenic Galectin-1 Delay Onset of Autoimmune Diabetes in Mice
J. Immunol.,
October 15, 2006;
177(8):
5278 - 5289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. C. Rogner, F. Lepault, M.-C. Gagnerault, D. Vallois, J. Morin, P. Avner, and C. Boitard
The Diabetes Type 1 Locus Idd6 Modulates Activity of CD4+CD25+ Regulatory T-Cells
Diabetes,
January 1, 2006;
55(1):
186 - 192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Alba, M. C. Puertas, J. Carrillo, R. Planas, R. Ampudia, X. Pastor, F. Bosch, R. Pujol-Borrell, J. Verdaguer, and M. Vives-Pi
IFN{beta} Accelerates Autoimmune Type 1 Diabetes in Nonobese Diabetic Mice and Breaks the Tolerance to {beta} Cells in Nondiabetes-Prone Mice
J. Immunol.,
December 1, 2004;
173(11):
6667 - 6675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. V. Tarbell, S. Yamazaki, K. Olson, P. Toy, and R. M. Steinman
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes
J. Exp. Med.,
June 7, 2004;
199(11):
1467 - 1477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Flodstrom-Tullberg, D. Yadav, R. Hagerkvist, D. Tsai, P. Secrest, A. Stotland, and N. Sarvetnick
Target Cell Expression of Suppressor of Cytokine Signaling-1 Prevents Diabetes in the NOD Mouse
Diabetes,
November 1, 2003;
52(11):
2696 - 2700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Silva, N. Petrovsky, L. Socha, R. Slattery, P. Gatenby, and B. Charlton
Mechanisms of Accelerated Immune-Mediated Diabetes Resulting from Islet {beta} Cell Expression of a Fas Ligand Transgene
J. Immunol.,
May 15, 2003;
170(10):
4996 - 5002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M A Kelly, M L Rayner, C H Mijovic, and A H Barnett
Molecular aspects of type 1 diabetes
Mol. Pathol.,
February 1, 2003;
56(1):
1 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Szanya, J. Ermann, C. Taylor, C. Holness, and C. G. Fathman
The Subpopulation of CD4+CD25+ Splenocytes That Delays Adoptive Transfer of Diabetes Expresses L-Selectin and High Levels of CCR7
J. Immunol.,
September 1, 2002;
169(5):
2461 - 2465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Grattan, Q.-S. Mi, C. Meagher, and T. L. Delovitch
Congenic Mapping of the Diabetogenic Locus Idd4 to a 5.2-cM Region of Chromosome 11 in NOD Mice: Identification of Two Potential Candidate Subloci
Diabetes,
January 1, 2002;
51(1):
215 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Winer, I. Astsaturov, R. K. Cheung, L. Gunaratnam, V. Kubiak, M. A. Cortez, M. Moscarello, P. W. O'Connor, C. McKerlie, D. J. Becker, et al.
Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis
J. Immunol.,
February 15, 2001;
166(4):
2831 - 2841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lepault and M. C. Gagnerault
Characterization of Peripheral Regulatory CD4+ T Cells That Prevent Diabetes Onset in Nonobese Diabetic Mice
J. Immunol.,
January 1, 2000;
164(1):
240 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Lejon C. and G. Fathman
Isolation of Self Antigen-Reactive Cells from Inflamed Islets of Nonobese Diabetic Mice Using CD4high Expression as a Marker
J. Immunol.,
November 15, 1999;
163(10):
5708 - 5714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Vallance, F. Galeazzi, S. M. Collins, and D. P. Snider
CD4 T Cells and Major Histocompatibility Complex Class II Expression Influence Worm Expulsion and Increased Intestinal Muscle Contraction during Trichinella spiralis Infection
Infect. Immun.,
November 1, 1999;
67(11):
6090 - 6097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Susan Wong, I. Visintin, L. Wen, J. Granata, R. Flavell, and C. A. Janeway Jr.
The Role of Lymphocyte Subsets in Accelerated Diabetes in Nonobese Diabetic-Rat Insulin Promoter-B7-1 (NOD-RIP-B7-1) Mice
J. Exp. Med.,
June 15, 1998;
187(12):
1985 - 1993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dahlen, K. Dawe, L. Ohlsson, and G. Hedlund
Dendritic Cells and Macrophages Are the First and Major Producers of TNF-{alpha} in Pancreatic Islets in the Nonobese Diabetic Mouse
J. Immunol.,
April 1, 1998;
160(7):
3585 - 3593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Slover and G. S. Eisenbarth
Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets
Endocr. Rev.,
April 1, 1997;
18(2):
241 - 258.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|